BioCentury
ARTICLE | Company News

United Therapeutics' earnings underperform

May 2, 2018 8:05 PM UTC

United Therapeutics Corp. (NASDAQ:UTHR) fell $7.36 to $104.31 on Wednesday, losing about $320 million in market cap, after reporting 1Q18 earnings below expectations.

The biotech said 1Q18 non-GAAP EPS slid 4% to $3.76 for the quarter, below the Street's estimate of $4. The company also missed on revenue, reporting a 5% decline to $389.2 million, compared with consensus estimate of $395.2 million. ...